BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bridgewater-Based Aptalis Pharmaceutical Technologies Files To Raise $500 Million In IPO


12/27/2013 6:38:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aptalis Holdings, the pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, filed to raise $500 million in an initial public offering in the U.S. The figure is a placeholder used to calculate fees and may change. Aptalis plans to use the proceeds to repay debt, and some of the company’s existing stockholders also plan to sell shares, according to today’s filing.

Help employers find you! Check out all the jobs and post your resume.


Read at nj.com
Read at Fox News
Read at Bloomberg
Read at Reuters

nj.com
Fox News
Bloomberg
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES